Skip to main content
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NYSE · Healthcare · Profile

Abbott Laboratories (ABT) stock profile and business model

What Abbott Laboratories does, how the business earns money, and how valuation, peers, ownership, and risk shape the TECHi profile.

Section freshness

Prices as of Sep 4, 4:04 PM EDT · Fundamentals checked Sep 8, 3:20 AM EDT · Statements Mar 31, 2026

Investor profile snapshot

ABT live price, business model and key metrics

Start with the live market print, then use this profile to connect Abbott Laboratories's operating model with revenue, margins, peer context, and investor risk.

Market closedLatest regular-session print

$108.33

-$0.4600(-0.42%)4:04 PM ET - vs previous closei

Quote as of Sep 4, 2026, 4:04 PM EDT

NYSE market is closed. Showing the latest available regular-session trade from Sep 4, 2026, 4:04 PM EDT.

Market data source

Today37%
$107.36L Sep 4 '26$110.01H Sep 4 '26
52-week47%
$81.97$137.49
Long-term ranges5Y, 10Y, Since first print
5Y43%
$81.97L May 11 '26$142.60H Dec 27 '21
10Y67%
$37.38L Dec 1 '16$142.60H Dec 27 '21
Since first print72%
$19.80L May 1 '09$142.60H Dec 27 '21

1Y · USD · 254 pts

$108.33

Last close · Sep 26

-16.15%Open summary
Market-data preview · Sep 25 to Sep 261-year price range
ABT one-year price chartServer-rendered SVG chart showing ABT price history.
1Y High$137.491Y Low$81.97

ABT one-year SVG chart preview from 2025-09-03 to 2026-09-04.

Live price

$108.33

Live during market hours

Market cap

$187.45B

Equity scale

Analyst view

Buy

Target $120.20 (+10.96% implied)

Company · Profile

About Abbott Laboratories (ABT)

Sector, leadership, and how Abbott Laboratories earns its revenue.

Abbott Laboratories

NYSE · ABT · US

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector
Healthcare
Industry
Health Care
Headquarters
Abbott Park, IL, United States
Country
US
Founded
1937
Employees
122,000
CEO
Mr. Robert B. Ford
Exchange
NYSE

Business identity

Abbott Laboratories company facts and operating footprint

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector
Healthcare
Industry
Health Care
Headquarters
Abbott Park, IL, United States
Founded
1937
Employees
122,000
CEO
Mr. Robert B. Ford
Country
US
Exchange
NYSE
Registration and filing identifiersShow
Asset type
Common Stock
Fiscal year end
December
Latest quarter
Mar 31, 2026
CIK
0000001800

Key metrics

ABT valuation, revenue and margin profile

Full statistics
Market cap
$187.45B
Equity scale
Revenue TTM
$45.13B
Trailing twelve months
Net margin
13.91%
Profit after expenses
Revenue growth
7.78%
Latest YoY quarter
Free cash flow
$916.00M
Reported in USD

Margin quality snapshot

Gross margin37.08%
Operating margin17.07%
Net margin13.91%

Competitors

ABT competitors and peer context

TickerCompanyPriceMove
ISRGIntuitive Surgical$366.70-0.85%

Risk heatmap

ABT business risks investors should monitor

Valuation sensitivity

Elevated

35.06x

Use the forward P/E and PEG context before treating the profile as cheap or expensive.

Balance-sheet flexibility

Monitor

D/E 0.65 · CR 1.39

Debt load and near-term liquidity shape how much strategic patience the company has.

Growth durability

Monitor

7.78%

Latest YoY revenue growth is the first check on whether the business model is still expanding.

Market sensitivity

Monitor

Beta 0.59

Higher beta can amplify drawdowns when rates, earnings expectations, or sector appetite shift.

Regulatory and operating pressure

Elevated

Healthcare

Clinical, reimbursement, approval, and policy shifts can change revenue timing and product economics.

ABT ownership and registration profile

Float shares
1.72B
Insider ownership
0.50%
Institutional ownership
81.91%
Address
100 Abbott Park Road, Abbott Park, IL, 60064-6400, United States

Size & scale

Market cap
$187.45B
Enterprise value
$214.70B
Shares outstanding
1.74B
Currency
USD

Frequently asked

Common questions.

What does Abbott Laboratories do?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Where does TECHi source the ABT profile?

ABT profile facts come from company filings and TECHi's market-data providers; any detail that is not available is left blank rather than inferred.